by Jackie (née Heneghan) Peck | Oct 31, 2016 | Blog, NHS, Pharmacist, Pharmacy Brands, pharmacy business development, Pharmacy Suppliers
In April 2016, NHS England confirmed it would fund a further 1,500 pharmacists to work alongside GPs. Some CCGs now plan manage their patient’s repeats and take then away from the local pharmacies. Now we are about to see pharmacy payments slashed and clinical...
by Jackie (née Heneghan) Peck | Oct 31, 2016 | Blog, NHS, Pharmacist, Pharmacy Brands, pharmacy business development, Pharmacy Suppliers
Pharmacists and Physios have been working in GP surgeries now for over a year and the aim is to relieve pressure on the GPs so they have time for the more complicated patients. How is the segregation of patients carried out in practice and how are going to measure...
by Jackie (née Heneghan) Peck | Oct 31, 2016 | Blog, NHS, Pharmacist, Pharmacy Brands, pharmacy business development, Pharmacy Suppliers
Quality Payments can be claimed at the end of April 2017 and again at the end of November 2017. The April payments will be made at the end of June, beginning of July. Do you meet the criteria? First steps are as follows: You must offer at least one advanced service...
by Jackie (née Heneghan) Peck | Oct 18, 2016 | Blog, Pharmacist, Pharmacy Brands, pharmacy business development, Pharmacy Suppliers
What are the hidden costs to scrapping a pharmacy repeat dispensing service? There will pressure on the overstretched surgery staff! Trying to get through on the phone to a surgery now is bad enough but if every person who forgets to put his repeat slip in on time to...
by Jackie (née Heneghan) Peck | Oct 18, 2016 | Blog, Pharmacist, Pharmacy Brands, pharmacy business development, Pharmacy Suppliers
Is your pharmacy at risk by the proposed funding cuts? Can you survive a proposed 12% funding cut? Have you looked at your figures? The C +D have reported a leaked government document which suggests that only 1,380 pharmacy sites out of 11,674 in England will...
by Jackie (née Heneghan) Peck | Jul 19, 2015 | Analyisis, Behind the scenes, Blog, Falsified Medicines, Good Distribution Practice - GDP, MHRA, Pharmacy Suppliers, Regulation, RP, WDA(H), WDA(H)
In May, the FDA in conjunction with international law enforcements agencies enforced a major crackdown on illegal and crackdown medications with action taken against 1,050 websites. Seized products were found to have originated in India, China, Hong Kong and...
